UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024720
Receipt number R000028439
Scientific Title Research about lifestyle and immune function.
Date of disclosure of the study information 2016/11/04
Last modified on 2019/11/07 11:03:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research about lifestyle and immune function.

Acronym

Research about lifestyle and immune function.

Scientific Title

Research about lifestyle and immune function.

Scientific Title:Acronym

Research about lifestyle and immune function.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Infectious disease Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to reveal the determinants in causing individual differences in immune function and the effect of infections by comparing with people who have strong and weak resistance.

Basic objectives2

Others

Basic objectives -Others

General survey to reveal the correlation among lifestyle, immune function and infection diseases.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Questionnaire survey about lifestyle, rate of infection diseases

Key secondary outcomes

Indicators of immune function;
ex) activity of immune cells, deep body temperature, threshold to feel the bitter taste


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese.
Age >=20 and <=59 years.
2) Informed consent provided.
3) Able to follow the instructions of the study team.

Key exclusion criteria

1) Serious disorder
2)Regular hospital visit and medication intended to cure
3)Unable to answer questionnaires containing personal informations
4)women who are or may be pregnant and who are lactating
5)Subjects judged by the investigator/project leader to be ineligible for other reasons

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriyasu Ota

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7828

Email

ota.noriyasu@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kaori Kobayashi

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7687

Homepage URL


Email

kobayashi.kaori7@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社(栃木県)


Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 15 Day

Date of IRB

2016 Year 10 Month 15 Day

Anticipated trial start date

2016 Year 11 Month 05 Day

Last follow-up date

2018 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Regular employee at Kao Corporation as of 4 Nov.2016.
Key inclusion criteria
1) Japanese.
Age >=20 and <=59 years.
2) Informed consent provided.
3) Able to follow the instructions of the study team.

-Questionnaire survey about lifestyle, rate of infection diseases
-Indicators of immune function;
ex) activity of immune cells, deep body temperature, threshold to feel the bitter taste


Management information

Registered date

2016 Year 11 Month 04 Day

Last modified on

2019 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028439


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name